In rats with heart failure, IL-10 therapy significantly improved post-MI left ventricular function by reducing IL-6 and TNF-α, whilst in ischemia-reperfusion injury, IL-10 therapy reduced inflammation and cardiomyocyte death [66,67]. Here, IL6 is linked to heart failure.